1Department of Family Medicine and Community Health, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, USA
2Corner Medical, Northeastern Vermont Regional Hospital, Lyndonville, USA
35Savannah Campus, Mercer University School of Medicine, Savannah, USA
4Cancer Institute of New Jersey, New Brunswick, USA
American Journal of Cancer Prevention.
2013,
Vol. 1 No. 1, 4-8
DOI: 10.12691/ajcp-1-1-2
Copyright © 2013 Science and Education PublishingCite this paper: John G. Scott, Eric K. Shaw Asia Friedman, Jeanne M. Ferrante. Emotional Consequences of Persistently Elevated PSA with Negative Prostate Biopsies.
American Journal of Cancer Prevention. 2013; 1(1):4-8. doi: 10.12691/ajcp-1-1-2.
Correspondence to: John G. Scott, Department of Family Medicine and Community Health, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, USA. Email:
j.scott@nvrh.orgAbstract
False positive results are among the most common adverse outcomes of cancer screening tests. Up to 75% of men with an elevated prostate specific antigen (PSA) have had a negative prostate biopsy. Adverse emotional effects of false positive prostate cancer screening have been documented using surveys, but there is nothing in this literature describing the lived experience of having a false positive PSA. In a qualitative interview study of sixteen men who had false positive PSAs, we found that all subjects experienced transient anxiety while waiting for the results of their prostate biopsies. In addition there were three persistent emotional responses: (1) increased fear of cancer; (2) relief with increased vigilance; (3) relief with less worry about elevated PSA. The attitude and recommendations of urologists influenced the emotional responses. Some men expressed frustration with the PSA as a screening test. Many men had multiple negative prostate biopsies. These data suggest that there should be more effort to develop guidelines for subsequent prostate biopsies after an initial negative biopsy, and more effort to encourage primary care clinicians and urologists to discuss emotional risks of PSA testing with their patients.
Keywords